What is the official website of Biocon ?

The official website of Biocon is http://www.biocon.com.

What is Biocon's cybersecurity risk score?

Biocon has an AI-generated cybersecurity risk score of 773 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has Biocon experienced?

According to Rankiteo, Biocon currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has Biocon been affected by any supply chain cyber incidents ?

According to Rankiteo, Biocon has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does Biocon have SOC 2 Type 1 certification ?

According to Rankiteo, Biocon is not certified under SOC 2 Type 1.

Does Biocon have SOC 2 Type 2 certification ?

According to Rankiteo, Biocon does not hold a SOC 2 Type 2 certification.

Does Biocon comply with GDPR ?

According to Rankiteo, Biocon is not listed as GDPR compliant.

Does Biocon have PCI DSS certification ?

According to Rankiteo, Biocon does not currently maintain PCI DSS compliance.

Does Biocon comply with HIPAA ?

According to Rankiteo, Biocon is not compliant with HIPAA regulations.

Does Biocon have ISO 27001 certification ?

According to Rankiteo,Biocon is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does Biocon operate in ?

Biocon operates primarily in the Biotechnology Research industry.

How many employees does Biocon have ?

Biocon employs approximately 11,558 people worldwide.

Does Biocon own any subsidiaries ?

Biocon presently has no subsidiaries across any sectors.

How many LinkedIn followers does Biocon have ?

Biocon's official LinkedIn profile has approximately 1,042,225 followers.

What is the NAICS classification code for Biocon ?

Biocon is classified under the NAICS code 541714, which corresponds to Research and Development in Biotechnology (except Nanobiotechnology).

Does Biocon have a Crunchbase profile ?

No, Biocon does not have a profile on Crunchbase.

Does Biocon have a LinkedIn profile ?

Yes, Biocon maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/biocon.

How many cybersecurity incidents has Biocon experienced ?

As of September 13, 2026, Rankiteo reports that Biocon has not experienced any cybersecurity incidents.

How many peer or competitor companies does Biocon have ?

Biocon has an estimated 4,760 peer or competitor companies worldwide.

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

Biocon

Boost Score +25 with badge (5 left)

773

/1000

Fair

798

/1000

Fair

Biocon Vendor Cyber Rating & Cyber Score

biocon.com

Add Your Compliance Badge

Biocon: Enhancing Global Healthcare Biocon Limited, publicly listed in 2004, is India's largest and fully-integrated, innovation-led biopharmaceutical company. It is an emerging global biopharmaceutical enterprise serving customers in over 120 countries. Driven by a vision to enhance global healthcare through innovative and affordable biopharmaceuticals, we have enabled access to advanced therapies for diseases that are chronic, where medical needs are largely unmet and treatment costs are high. The early anticipation of the increasing dominance of biologics in global development pipelines helped us to be ahead of the curve in crafting a differentiated product portfolio based on fermentation and recombinant technologies, which

Biocon

Biocon CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

No data available

Loading…

A.I.

Biocon Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for Biocon

Incidents vs Biotechnology Research Industry Avg (This Year)

No incidents recorded for Biocon in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for Biocon in 2026.

Incident Types Biocon vs Biotechnology Research Industry Avg (This Year)

No incidents recorded for Biocon in 2026.

Incident History - Biocon (X = Date, Y = Severity)

Loading…

SUBSIDIARY

Biocon Subsidiaries

Parent Company

Biocon

Biotechnology Research

Website: http://www.biocon.com

Company Size: 5,001-10,000 employees

No subsidiary data available for this company.

Loading…

Biocon Similar Companies

Charles River Laboratories

criver.com

At Charles River, we are guided by our strong purpose—to create healthier lives—which centers around the patients who rely on the therapeutics we help to develop, the animals in our care, to our planet, and to the passionate and skilled people who are at the heart of our organization and make it all possible. #DrugDiscovery #Biotech #Biotechnology #Pharmaceuticals #CRL

ICON plc

iconplc.com

Since our foundation in Dublin, Ireland in 1990, our mission has been to help our clients to accelerate the development of drugs and devices that save lives and improve quality of life. We do this by delivering best in class information, solutions and performance, with an unyielding focus on quality at all times. We offer a full range of consulting, development and commercialisation services from a global network of offices in 53 countries. We focus our innovation on the factors that are critical to our clients – reducing time to market, reducing cost, and increasing quality – and our global team of experts has extensive experience in a broad range of therapeutic areas.

CSL

cb csl.com

CSL is a leading global biopharma company with a dynamic portfolio of lifesaving medicines, including those that treat haemophilia and immune deficiencies, vaccines to prevent influenza, and therapies in iron deficiency, dialysis and nephrology. Since our start in 1916, we have been driven by our promise to save lives using the latest technologies. Today, CSL – including our businesses, CSL Behring, CSL Seqirus, and CSL Vifor – provides lifesaving products to patients in more than 100 countries and employs 29,000+ people. Our unique combination of commercial strength, R&D focus and operational excellence enables us to identify, develop and deliver innovations so our patients can live life to the fullest. See our community guidelines: https://bit.ly/3Bs17Ra

Thermo Fisher Scientific

thermofisher.com

About Thermo Fisher Scientific Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.

Eurofins

cb eurofins.com

Since 1987, Eurofins has grown from one laboratory in Nantes, France to over 65,000 staff across a network of independent companies in 60 countries, operating over 950 laboratories. Performing over 450 million tests every year, Eurofins offers a portfolio of over 200,000 analytical methods to evaluate the safety, identity, composition, authenticity, origin, traceability and purity of biological substances and products, as well as providing innovative clinical diagnostic testing services, as one of the leading global emerging players in specialised clinical diagnostics testing. Ever since its IPO on the French stock exchange in 1997, Eurofins has been one of the fastest growing listed European companies.

Fortrea

fortrea.com

Fortrea (Nasdaq: FTRE) is a leading global clinical research organization (CRO) dedicated to providing innovative clinical development solutions to the life sciences industry. With over 30 years of clinical research experience, Fortrea has evolved from Covance and Labcorp into a pureplay CRO built for biotech, biopharma, medical device and diagnostic innovators. Fortrea collaborates with both emerging and established companies to deliver agile, fit-for-purpose full service (FSO), functional service (FSP) and hybrid solutions. Fortrea provides comprehensive Phase I-IV clinical trial management, clinical pharmacology, and consulting services, backed by deep experience in more than 20 therapeutic areas. Operating in approximately 100 countries, our diverse and talented team brings scientific rigor, operational excellence, and a strong investigator site network to every trial. By combining the best of our legacy experience with forward-thinking innovation, Fortrea brings predictability to clinical trial execution and helps transform aspirations into outcomes. Together, exceptional is possible. Learn more at Fortrea.com

bioMérieux

biomerieux.com

A family-owned company, bioMérieux has grown to become a world leader in the field of in vitro diagnostics. Our entrepreneurial adventure, begun over a century ago, is driven by an unrelenting commitment to improve public health worldwide. Since 1963, we've been paving the way in the field of in vitro diagnostics and have contributed greatly to improving public health and making the world a healthier place. The solutions that our teams imagine, develop and manufacture are key to enable healthcare professionals and industry players to make confident decisions to improve patient outcome and ensure consumer safety.

Syneos Health

cb syneoshealth.com

Syneos Health® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities. We bring together a talented team of professionals with a deep understanding of patient and physician behaviors and market dynamics. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. Syneos Health supports a diverse, equitable and inclusive culture that cares for colleagues, customers, patients, communities and the environment.

Amgen

amgen.com

Amgen harnesses the best of biology and technology to fight the world’s toughest diseases, and make people’s lives easier, fuller and longer. We helped establish the biotechnology industry, and we remain on the cutting-edge of innovation, using technology and human genetic data to push beyond what’s known today. Our investment in research and development has yielded a robust pipeline that builds on our existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases. Amgen is one of 30 companies comprising the Dow Jones Industrial Average®, and part of the Nasdaq-100 Index®. In 2024, Amgen was named one of the “World’s Most Innovative Companies” by Fast Company and one of “America’s Best Large Employers” by Forbes. For more information, visit Amgen.com and follow us on X, LinkedIn, Instagram, TikTok, YouTube and Threads. 🔗 Community Guidelines: https://wwwext.amgen.com/community-guidelines 🔗Global Privacy Statement Directory: www.amgen.com/dp Special Advisory: Please be cautious of scam recruitment offers claiming to be from Amgen. Such scams may come from various sources, including fake websites and/or unsolicited emails and seek to obtain personal data or payment from victims by offering jobs that do not exist. Please be advised that Amgen would never ask for payment to progress a job application. When in doubt, please check to see if the position in question is posted on this website before applying. Additionally, please report any suspicious recruiting activity to https://complaint.ic3.gov/ and thank you for your assistance.

Loading…

NEWS

Biocon CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

March 16, 2026 03:23 AM

CISOs are becoming the boardroom’s operating system, say industry leaders

At ETCISO Secufest 2026, cybersecurity and privacy leaders said boards now expect CISOs to translate resilience, trust, and regulatory risk...

Read Article

February 18, 2026 08:00 AM

US welcomes India's participation in American AI exports programme

The American AI Exports Programme will soon issue a public call for proposals from industry-led consortia to deliver integrated AI packages.

Read Article

December 24, 2025 08:00 AM

Why did Blue Cloud Softech Solutions share price rise 3% in trade today?

Blue Cloud Softech Solutions share price rose today after the company announced a strategic Memorandum of Understanding (MoU) with ConnectM...

Read Article

November 19, 2025 08:00 AM

Mangaluru’s Jayshree Ullal tops list of India’s richest women entrepreneurs

Mangalore Today | Latest main news of mangalore, udupi - Page Mangaluru-s-Jayshree-Ullal-tops-list-of-India-s-richest-women-entrepreneurs.

Read Article

September 18, 2025 07:00 AM

TechD Cybersecurity IPO booked 718x; check allotment status, latest GMP

Investors who applied for the TechD Cybersecurity IPO can check their allotment status online through the NSE or the registrar's website,...

Read Article

April 07, 2025 07:00 AM

Career lessons from Biocon Biologics Global DPO: Tanin Chakraborty on compliance, culture, curiosity

In the early 2000s, data privacy and cybersecurity were still niche concerns in most organizations—rarely discussed in boardrooms and often...

Read Article

January 07, 2025 08:00 AM

Biocon Biologics Secures Regulatory Approval for Ustekinumab BS

Biocon Biologics Ltd., the subsidiary of Biocon Ltd., is now a forerunner in achieving an important milestone; the Pharmaceuticals and...

Read Article

November 22, 2024 08:00 AM

Bengaluru Tech Summit 2024 Concludes with Major Milestones in Tech, Innovation, and Cybersecurity

The three-day Bengaluru Tech Summit (BTS) 2024, held at the Bangalore Palace, concluded today with resounding success, breaking new ground...

Read Article

October 03, 2024 07:00 AM

Regulatory frameworks essential in cybersecurity space: Quick Heal CEO

Regulations play a vital role in shaping the cybersecurity landscape by setting clear standards for protecting sensitive data and ensuring...

Read Article

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-90647

SUMMARY

ASE/Kalkitech ASE2000 V2 Communication Test Set 2.35 through 2.37 on Windows contains an improper certificate validation vulnerability in the IEC 60870-5-104 TLS client (Task Mode). This allows a network-positioned attacker to bypass certificate validation via a certificate with multiple simultaneous faults, enabling a Man-in-the-Middle attack on protected communications.

Published

Date2026-09-12

Updated

Date2026-09-12

RISK INFORMATION (Score: 7.4)

cvss3

Base Score: 7.4

Complexity: HIGH

CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:H/I:H/A:N

cvss4

Base Score: 9.1

Complexity: HIGH

CVSS:4.0/AV:N/AC:H/AT:N/PR:N/UI:N/VC:H/VI:H/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

5.2

Exploitability

2.2

REFERENCES

https://www.ase-systems.com/wp-content/uploads/2026/07/CYB_2026_86278_Advisory_v1.0.pdf

CVE-2026-90487

SUMMARY

A vulnerability was found in Xuxueli xxl-job up to 3.4.2. Affected by this issue is some unknown functionality of the file xxl-job-admin/src/main/java/com/xxl/job/admin/business/controller/JobGroupController.java. The manipulation results in improper privilege management. The attack may be launched remotely. The exploit has been made public and could be used. The vendor was contacted early about this disclosure but did not respond in any way.

Published

Date2026-09-12

Updated

Date2026-09-12

RISK INFORMATION (Score: 4.3)

cvss2

Base Score: 4.0

Complexity: LOW

AV:N/AC:L/Au:S/C:P/I:N/A:N

cvss3

Base Score: 4.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:N

cvss4

Base Score: 2.1

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:N/VA:N/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

1.4

Exploitability

2.8

REFERENCES

CVE-2026-90486

SUMMARY

A vulnerability has been found in openstatusHQ openstatus up to f04c827112f30a11d571ebdad3892826034d6265. Affected by this vulnerability is an unknown functionality of the file apps/status-page/src/lib/proxy/resolve-custom-domain-rewrite.ts. The manipulation leads to server-side request forgery. The attack may be initiated remotely. This product uses a rolling release model to deliver continuous updates. As a result, specific version information for affected or updated releases is not available. The identifier of the patch is 86f370c9c20074c3c3fdec53a359874b8e670fd4. It is suggested to install a patch to address this issue. This issue got fixed with a silent patch.

Published

Date2026-09-12

Updated

Date2026-09-12

RISK INFORMATION (Score: 6.3)

cvss2

Base Score: 7.5

Complexity: LOW

AV:N/AC:L/Au:N/C:P/I:P/A:P

cvss3

Base Score: 6.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:L/I:L/A:L

cvss4

Base Score: 5.3

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:P/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.4

Exploitability

2.8

REFERENCES

CVE-2026-79300

SUMMARY

SEP sesam before 5.2.0.24 mishandles User Authorization with MFA. If AD authentication is configured and MFA is enforced, an attacker can create a second OTP access capability. SEP sesam and Active Directory handle username capitalization differently, which may allow multiple SEP sesam user accounts to be created for the same Active Directory (AD) account. Active Directory treats usernames as case-insensitive, while SEP sesam distinguishes between different letter casing. As a result, the same AD user can be represented by multiple SEP sesam user accounts that differ only in username capitalization. When Active Directory authentication is configured and multi-factor authentication (MFA) is enforced, this behavior may allow an additional OTP Authenticator to be registered for the same AD account, reducing the effectiveness of MFA protection.

Published

Date2026-09-12

Updated

Date2026-09-12

RISK INFORMATION (Score: 3.5)

cvss3

Base Score: 3.5

Complexity: HIGH

CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:C/C:N/I:L/A:N

Impact Score

1.4

Exploitability

1.8

REFERENCES

https://wiki.sep.de/wiki/index.php/Release_Notes_5.2.0_Artemis#fixed

CVE-2026-90485

SUMMARY

A flaw has been found in IOBit Uninstaller 15.5.0.11. Affected by this issue is the function sub_11838 of the file IURegistryFilter.sys of the component IOCTL Dispatch Handler. This manipulation causes null pointer dereference. The attack requires local access. The exploit has been published and may be used. Identical IURegistryFilter.sys ships across multiple IObit families. The vendor was contacted early about this disclosure but did not respond in any way.

Published

Date2026-09-12

Updated

Date2026-09-12

RISK INFORMATION (Score: 5.5)

cvss2

Base Score: 4.6

Complexity: LOW

AV:L/AC:L/Au:S/C:N/I:N/A:C

cvss3

Base Score: 5.5

Complexity: LOW

CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:N/I:N/A:H

cvss4

Base Score: 5.4

Complexity: LOW

CVSS:4.0/AV:L/AC:L/AT:N/PR:L/UI:N/VC:N/VI:N/VA:H/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.6

Exploitability

1.8

REFERENCES

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…

Badge your company to reduce your risk score and your cyber insurance costs!

Trusted by insurers. Chosen by leaders.

Biocon Vendor Cyber Rating & Cyber Score

Biocon A.I CyberSecurity Scoring

Biocon CyberSecurity News & History

Biocon Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Incident Predictions locked

A.I Risk Score Likelihood 3 - 6 - 9 months

A.I. Risk Score Predictions locked

Underwriter Stats for Biocon

Incidents vs Biotechnology Research Industry Avg (This Year)

Incidents vs All-Companies Average (This Year)

Incident Types Biocon vs Biotechnology Research Industry Avg (This Year)

Incident History - Biocon (X = Date, Y = Severity)

Biocon Subsidiaries

Parent Company

Biocon

Biocon Similar Companies

Charles River Laboratories

ICON plc

CSL

Thermo Fisher Scientific

Eurofins

Fortrea

bioMérieux

Syneos Health

Amgen

Biocon CyberSecurity News

CISOs are becoming the boardroom’s operating system, say industry leaders

US welcomes India's participation in American AI exports programme

Why did Blue Cloud Softech Solutions share price rise 3% in trade today?

Mangaluru’s Jayshree Ullal tops list of India’s richest women entrepreneurs

TechD Cybersecurity IPO booked 718x; check allotment status, latest GMP

Career lessons from Biocon Biologics Global DPO: Tanin Chakraborty on compliance, culture, curiosity

Biocon Biologics Secures Regulatory Approval for Ustekinumab BS

Bengaluru Tech Summit 2024 Concludes with Major Milestones in Tech, Innovation, and Cybersecurity

Regulatory frameworks essential in cybersecurity space: Quick Heal CEO

Global CVEs (Not Company-Specific)

Access Data Using Our API

What Do We Measure ?

These are some of the factors we use to calculate the overall score:

Rankiteo

Biocon CyberSecurity News & History

Biocon Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Incident Predictions locked

A.I Risk Score Likelihood 3 - 6 - 9 months

A.I. Risk Score Predictions locked

Underwriter Stats for Biocon

Incidents vs Biotechnology Research Industry Avg (This Year)

Incidents vs All-Companies Average (This Year)

Incident Types Biocon vs Biotechnology Research Industry Avg (This Year)

Incident History - Biocon (X = Date, Y = Severity)

Biocon Subsidiaries

Parent Company

Biocon

Biocon Similar Companies

Charles River Laboratories

ICON plc

CSL

Thermo Fisher Scientific

Eurofins

Fortrea

bioMérieux

Syneos Health

Amgen

Biocon CyberSecurity News

CISOs are becoming the boardroom’s operating system, say industry leaders

US welcomes India's participation in American AI exports programme

Why did Blue Cloud Softech Solutions share price rise 3% in trade today?

Mangaluru’s Jayshree Ullal tops list of India’s richest women entrepreneurs

TechD Cybersecurity IPO booked 718x; check allotment status, latest GMP

Career lessons from Biocon Biologics Global DPO: Tanin Chakraborty on compliance, culture, curiosity

Biocon Biologics Secures Regulatory Approval for Ustekinumab BS

Bengaluru Tech Summit 2024 Concludes with Major Milestones in Tech, Innovation, and Cybersecurity

Regulatory frameworks essential in cybersecurity space: Quick Heal CEO

Global CVEs (Not Company-Specific)

Access Data Using Our API

What Do We Measure ?